DavidRosmarinMD
Dermatology • Indianapolis, INInstructor in Dermatology, Brigham and Women's Hospital
Dr. Rosmarin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 University Blvd
Ste 3240
Indianapolis, IN 46202Phone+1 317-948-8657Fax+1 317-944-7051
Education & Training
Boston University Medical CenterResidency, Dermatology, 2006 - 2009
New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 2005 - 2006
New York University School of MedicineClass of 2005
Certifications & Licensure
IN State Medical License 2022 - 2025
MA State Medical License 2008 - 2023
NY State Medical License 2013 - 2016- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Clinical Trials
- A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis Start of enrollment: 2016 Apr 01
- Topical Ruxolitinib for the Treatment of Vitiligo Start of enrollment: 2016 Jan 01
- Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa Start of enrollment: 2016 Jul 11
- Join now to see all
Publications & Presentations
PubMed
- A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Moni...Maria C Schneeweiss, Robert J Glynn, Richard Wyss, Priyanka Anand, Yinzhu Jin
The Journal of Investigative Dermatology. 2024-10-01 - Benzene in benzoyl peroxide-how worried should we be?John S Barbieri, Jenna L Streicher, David Rosmarin
Journal of the American Academy of Dermatology. 2024-10-01 - 1 citationsA Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council.Carter Haag, Andrew Alexis, Valeria Aoki, Robert Bissonnette, Andrew Blauvelt
The British Journal of Dermatology. 2024-09-10
Press Mentions
Adolescents with Vitiligo Achieve Higher Repigmentation Rates with Topical Ruxolitinib Than AdultsJuly 16th, 2024- Seeing Red with DupilumabMarch 1st, 2023
- Pivotal Phase 3 Data Showing Significant Improvements in Facial and Total Body Repigmentation with Ruxolitinib Cream (Opzelura™) in Vitiligo Published in New England Journal of MedicineOctober 20th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
